Showing results (721-730 of 785) with videos related to

Sort By:
Pageof 79
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
Stem Cell Research & Therapy|January 30, 2022
G protein-coupled receptor kinase 3 modulates mesenchymal stem cell proliferation and differentiation through sphingosine-1-phosphate receptor regulationJaime M Brozowski, Roman G Timoshchenko, D Stephen Serafin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2021
Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch OutcomesShintaro Akiyama, Jacob E Ollech, Victoria Rai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results from the Phase 2 GLADIATOR TrialSilvio Danese, Martina Goetsch, Laurent Peyrin-Biroulet, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
Gastroenterology|February 8, 2022
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 StudyWilliam J Sandborn, Geert R D'Haens, Walter Reinisch, et al.
Inflammatory Bowel Diseases|November 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by AgeAdam S Faye, David T Rubin, Corey A Siegel, et al.
Inflammatory Bowel Diseases|January 18, 2022
Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative ColitisJoseph Runde, Amarachi Erondu, Shintaro Akiyama, et al.
Nature Reviews. Gastroenterology & Hepatology|April 22, 2025
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health responseVirginia Solitano, Charles N Bernstein, Iris Dotan, et al.
Pageof 79